We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| AstraZeneca PLC | NASDAQ:AZN | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.205 | 0.27% | 76.005 | 76.00 | 76.02 | 76.49 | 75.92 | 76.47 | 805,138 | 14:50:55 |
From May 2019 to May 2024
AstraZeneca PLC and Amgen Inc reported Tezepelumab trial results on Tuesday. AstraZeneca, Amgen flashes between 0705 GMT and 0707 GMT incorrectly referred to Amgen as Amgem.
(END) Dow Jones Newswires
December 22, 2020 02:55 ET (07:55 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year AstraZeneca Chart |
1 Month AstraZeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
